![signed agreement](https://pinnacledigest.com/wp-content/uploads/2020/12/signed-agreement.jpg)
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, has